Anti-SARS-CoV-2 Monoclonal Antibodies ADM03820

Preferred Label : Anti-SARS-CoV-2 Monoclonal Antibodies ADM03820;

NCIt definition : A 1:1 mixture of two human immunoglobulin G1 (IgG1) monoclonal antibodies directed against the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), that can potentially be used for the prevention and treatment of COVID-19. Upon administration of anti-SARS-CoV-2 monoclonal antibodies ADM03820, the two monoclonal antibodies specifically target and non-competitively bind to SARS-CoV-2, thereby neutralizing SARS-CoV-2. This may slow the progression of the disease and accelerate recovery, and may potentially provide temporary protection against infection with SARS-CoV-2.;

Molecule name : ADM-03820; ADM 03820;

NCI Metathesaurus CUI : CL1770958;

Details

Origin ID

C182629;

UMLS CUI

C5565566;

Currated CISMeF NLP mapping
- ADM03820 [MeSH Supplementary Concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- ADM03820 [MeSH Supplementary Concept]
chemical_or_drug_has_mechanism_of_action
- Antigen Binding [NCIt concept]
concept_is_in_subset
- NCIt COVID-19 Agent Terminology [NCIt concept]
- NCIt COVID-19 Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients